BioSpace News Archive

AnPac Bio-Medical Science Co., Ltd. announced that on April 1, 2022, the Company received a Nasdaq Hearing Instructions letter (the “Letter”) from the Nasdaq Stock Market LLC.

Perrigo Company plc today announced that it has launched a private offering (the “Offering”) of $500 million aggregate principal amount of senior notes due 2030,

Alnylam Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline of the New Drug Application (NDA) for vutrisiran.

Pear Therapeutics, Inc. today announced a program to offer patients seeking treatment for substance use disorder (SUD) or opioid use disorder (OUD) access to a telehealth provider through its “find a provider tool”, along with in-person care options.

Orum Therapeutics today announced the formation of its scientific advisory board (SAB).

The V Foundation for Cancer Research raised over $2.4 million at the inaugural Sonoma Epicurean weekend, held March 31 - April 3 in Sonoma County’s renowned wine country.

Lucid Diagnostics Inc. today announced that a newly updated American College of Gastroenterology (“ACG”) clinical guideline supports esophageal precancer (“Barrett’s Esophagus”, “BE”) screening to prevent highly lethal esophageal cancer (“EAC”) utilizing its EsoGuard® DNA Test on samples collected with its EsoCheck® Cell Collection Device.

Zealand Pharma A/S announced that Chief Executive Officer Adam Steensberg and Chief Financial Officer Matthew Dallas are scheduled to participate in the 21st Annual Needham Virtual Healthcare Conference.

Vaxcyte, Inc. announced today that the first participants were dosed in the Phase 2 portion of its ongoing Phase 1/2 clinical study evaluating VAX-24 for the prevention of invasive pneumococcal disease (IPD) and pneumonia in adults.

eGenesis today announced the appointment of Eliezer Katz, M.D., FACS, as Chief Medical Officer (CMO).